Regarding combination therapies assessed in in-vivo, overexpressed APLN was reported to promote the maturation of the cancer vasculature and subsequently enhanced its immune therapy efficiency in orthotopic colon cancer models (Kidoya et al., 2012). This evidence concerns the gene APLN and colonic neoplasm.